| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.016 | 0.7 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.7 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.7 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |